According to a recent report, more than four million people living in low- to middle-income countries are now receiving antiretroviral therapy.

The report, released by the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), and the Joint United Nations Programme on HIV/AIDS (UNAIDS), details other improvements in HIV/AIDS care as well, including figures related to treatment, testing and counseling, women and children, and at-risk populations.

Forty two percent of the estimated 9.5 million people in need of antiretroviral therapy (ART) in low- to middle-income countries are receiving care.…

A recent study shows that pregnant women who are HIV positive may increase their immune response and decrease the amount of HIV in their bodies if given highly active antiretroviral therapy (HAART) during pregnancy.

HAART is typically composed of three to four different antiretroviral drugs and can help slow down replication of the virus and control HIV levels in the blood. For this reason antiretroviral therapy has proven successful in slowing the progression of HIV to AIDS and decreasing the likelihood of transmission of the virus to the fetus during…